# COVID-19 Vaccines Safety Tracking (CoVaST)

> **NCT04834869** · — · RECRUITING · sponsor: **Masaryk University** · enrollment: 30000 (estimated)

## Conditions studied

- Adverse Reaction to Vaccine
- COVID19 Vaccine

## Interventions

- **BIOLOGICAL:** BNT162b2
- **BIOLOGICAL:** mRNA-1273
- **BIOLOGICAL:** AZD1222
- **BIOLOGICAL:** CoronaVac
- **BIOLOGICAL:** Sinopharm
- **BIOLOGICAL:** Gam-COVID-Vac
- **BIOLOGICAL:** JNJ-78436735
- **BIOLOGICAL:** CVnCoV
- **BIOLOGICAL:** NVX-CoV2373
- **BIOLOGICAL:** BBV152

## Key facts

- **NCT ID:** NCT04834869
- **Lead sponsor:** Masaryk University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30000 (ESTIMATED)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834869, "COVID-19 Vaccines Safety Tracking (CoVaST)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04834869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*